Origins of breast cancer subtypes and therapeutic implications

Sacha Howell, Andrew H. Sims, Anthony Howell, Sacha J. Howell, Robert B. Clarke

    Research output: Contribution to journalArticlepeer-review


    This Review summarizes and evaluates the current evidence for the cellular origins of breast cancer subtypes identified by different approaches such as histology, molecular pathology, genetic and gene-expression analysis. Emerging knowledge of the normal breast cell types has led to the hypothesis that the subtypes of breast cancer might arise from mutations or genetic rearrangements occurring in different populations of stem cells and progenitor cells. We describe the common distinguishing features of these breast cancer subtypes and explain how these features relate both to prognosis and to selection of the most appropriate therapy. Recent data indicate that breast tumors may originate from cancer stem cells. Consequently, inhibition of stem-cell self-renewal pathways should be explored because of the likelihood that residual stem cells might be resistant to current therapies.
    Original languageEnglish
    Pages (from-to)516-525
    Number of pages9
    JournalNature Clinical Practice Oncology
    Issue number9
    Publication statusPublished - Sept 2007


    • therapeutic use: Antibodies, Monoclonal
    • administration & dosage: Antineoplastic Agents
    • classification: Breast Neoplasms
    • pathology: Cell Transformation, Neoplastic
    • Female
    • Gene Expression Profiling
    • Humans
    • therapeutic use: Selective Estrogen Receptor Modulators
    • pathology: Stem Cells
    • genetics: Tumor Markers, Biological


    Dive into the research topics of 'Origins of breast cancer subtypes and therapeutic implications'. Together they form a unique fingerprint.

    Cite this